C

Active Director Director DIN 09846620
DIN 09846620 First appointment Jan 2023 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value •••• Premium profile

About Chitra

Data last updated:

Chitra is a Director at Weevil Biotech Private Limited (since 2023). The company operates in Food And Beverages. Weevil Biotech Private Limited reported revenue of ₹3.3 Lakh (FY 2024).

DIN 09846620
Primary Designation Director
Industry Food And Beverages
First Appointment 03 Jan 2023
Oldest Company Age 3 yrs
Largest company Weevil Biotech Private Limited · ₹3.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Weevil Biotech Private Limited U24304TN2023PTC157929
Director03 Jan 20232023₹3.3 Lakh (FY 2024)Active

Board colleagues of Chitra

NameDINCompanyDesignation
Veeramani Velayutham09247557Weevil Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Weevil Biotech Private Limited
Premium access

Shareholding and investment profile for Chitra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chitra

Chitra currently holds 1 directorship: Weevil Biotech Private Limited (Director, since 03 Jan 2023, revenue ₹3.3 Lakh (FY 2024)).

Chitra was first appointed on 03 Jan 2023 as Director at Weevil Biotech Private Limited.

The current boards of Chitra's companies include Veeramani Velayutham (Weevil Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available